Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

United States Microbiome Therapeutics Market Report 2017

  • QYR2178886
  • 118 Pages
  • October 2017
  • Pharmaceuticals
Download Sample    Get Discount   
 
In this report, the United States Microbiome Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

The West

Southwest

The Middle Atlantic

New England

The South

The Midwest

with sales (volume), revenue (value), market share and growth rate of Microbiome Therapeutics in these regions, from 2012 to 2022 (forecast).

United States Microbiome Therapeutics market competition by top manufacturers/players, with Microbiome Therapeutics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

C3 Jian

Enterome Bioscience

Immuron

MicroBiome Therapeutics

OpenBiome

Osel

Ritter Pharmaceuticals

Second Genome

Seres Therapeutics

Synthetic Biologics

4D Pharma

AbbVie

ActoGeniX

Admera Health

Advanced Technology Ventures

Advancing Bio

AgBiome

AOBiome

APC Microbiome Institute

Assembly Biosciences

Avid Biotics

Azitra

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

Probiotic Type

Fructo-Oligosaccharides

Galacto-Oligosaccharides

Inulin

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Microbiome Therapeutics for each application, including

Antibiotic-Associated Diarrhoea (AAD)

Infectious Childhood Diarrhoea

Cholesterol

Inflammatory Bowel Disease (IBD)

Blood Pressure

Lactose Intolerance

Weight Loss

Vitamin Production

Bacterial Vaginosis (BV)

Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

United States Microbiome Therapeutics Market Report 2017

1 Microbiome Therapeutics Overview

1.1 Product Overview and Scope of Microbiome Therapeutics

1.2 Classification of Microbiome Therapeutics by Product Category

1.2.1 United States Microbiome Therapeutics Market Size (Sales Volume) Comparison by Type (2012-2022)

1.2.2 United States Microbiome Therapeutics Market Size (Sales Volume) Market Share by Type (Product Category) in 2016

1.2.3 Probiotic Type

1.2.4 Fructo-Oligosaccharides

1.2.5 Galacto-Oligosaccharides

1.2.6 Inulin

1.3 United States Microbiome Therapeutics Market by Application/End Users

1.3.1 United States Microbiome Therapeutics Market Size (Consumption) and Market Share Comparison by Application (2012-2022)

1.3.2 Antibiotic-Associated Diarrhoea (AAD)

1.3.3 Infectious Childhood Diarrhoea

1.3.4 Cholesterol

1.3.5 Inflammatory Bowel Disease (IBD)

1.3.6 Blood Pressure

1.3.7 Lactose Intolerance

1.3.8 Weight Loss

1.3.9 Vitamin Production

1.3.10 Bacterial Vaginosis (BV)

1.3.11 Others

1.4 United States Microbiome Therapeutics Market by Region

1.4.1 United States Microbiome Therapeutics Market Size (Value) Comparison by Region (2012-2022)

1.4.2 The West Microbiome Therapeutics Status and Prospect (2012-2022)

1.4.3 Southwest Microbiome Therapeutics Status and Prospect (2012-2022)

1.4.4 The Middle Atlantic Microbiome Therapeutics Status and Prospect (2012-2022)

1.4.5 New England Microbiome Therapeutics Status and Prospect (2012-2022)

1.4.6 The South Microbiome Therapeutics Status and Prospect (2012-2022)

1.4.7 The Midwest Microbiome Therapeutics Status and Prospect (2012-2022)

1.5 United States Market Size (Value and Volume) of Microbiome Therapeutics (2012-2022)

1.5.1 United States Microbiome Therapeutics Sales and Growth Rate (2012-2022)

1.5.2 United States Microbiome Therapeutics Revenue and Growth Rate (2012-2022)

2 United States Microbiome Therapeutics Market Competition by Players/Suppliers

2.1 United States Microbiome Therapeutics Sales and Market Share of Key Players/Suppliers (2012-2017)

2.2 United States Microbiome Therapeutics Revenue and Share by Players/Suppliers (2012-2017)

2.3 United States Microbiome Therapeutics Average Price by Players/Suppliers (2012-2017)

2.4 United States Microbiome Therapeutics Market Competitive Situation and Trends

2.4.1 United States Microbiome Therapeutics Market Concentration Rate

2.4.2 United States Microbiome Therapeutics Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Microbiome Therapeutics Manufacturing Base Distribution, Sales Area, Product Type

3 United States Microbiome Therapeutics Sales (Volume) and Revenue (Value) by Region (2012-2017)

3.1 United States Microbiome Therapeutics Sales and Market Share by Region (2012-2017)

3.2 United States Microbiome Therapeutics Revenue and Market Share by Region (2012-2017)

3.3 United States Microbiome Therapeutics Price by Region (2012-2017)

4 United States Microbiome Therapeutics Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)

4.1 United States Microbiome Therapeutics Sales and Market Share by Type (Product Category) (2012-2017)

4.2 United States Microbiome Therapeutics Revenue and Market Share by Type (2012-2017)

4.3 United States Microbiome Therapeutics Price by Type (2012-2017)

4.4 United States Microbiome Therapeutics Sales Growth Rate by Type (2012-2017)

5 United States Microbiome Therapeutics Sales (Volume) by Application (2012-2017)

5.1 United States Microbiome Therapeutics Sales and Market Share by Application (2012-2017)

5.2 United States Microbiome Therapeutics Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Microbiome Therapeutics Players/Suppliers Profiles and Sales Data

6.1 C3 Jian

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Microbiome Therapeutics Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 C3 Jian Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Enterome Bioscience

6.2.2 Microbiome Therapeutics Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Enterome Bioscience Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Immuron

6.3.2 Microbiome Therapeutics Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Immuron Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 MicroBiome Therapeutics

6.4.2 Microbiome Therapeutics Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 MicroBiome Therapeutics Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 OpenBiome

6.5.2 Microbiome Therapeutics Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 OpenBiome Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Osel

6.6.2 Microbiome Therapeutics Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Osel Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Ritter Pharmaceuticals

6.7.2 Microbiome Therapeutics Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Ritter Pharmaceuticals Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Second Genome

6.8.2 Microbiome Therapeutics Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Second Genome Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 Seres Therapeutics

6.9.2 Microbiome Therapeutics Product Category, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 Seres Therapeutics Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 Synthetic Biologics

6.10.2 Microbiome Therapeutics Product Category, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 Synthetic Biologics Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

6.11 4D Pharma

6.12 AbbVie

6.13 ActoGeniX

6.14 Admera Health

6.15 Advanced Technology Ventures

6.16 Advancing Bio

6.17 AgBiome

6.18 AOBiome

6.19 APC Microbiome Institute

6.20 Assembly Biosciences

6.21 Avid Biotics

6.22 Azitra

7 Microbiome Therapeutics Manufacturing Cost Analysis

7.1 Microbiome Therapeutics Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Microbiome Therapeutics

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Microbiome Therapeutics Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Microbiome Therapeutics Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Microbiome Therapeutics Market Size (Value and Volume) Forecast (2017-2022)

11.1 United States Microbiome Therapeutics Sales Volume, Revenue Forecast (2017-2022)

11.2 United States Microbiome Therapeutics Sales Volume Forecast by Type (2017-2022)

11.3 United States Microbiome Therapeutics Sales Volume Forecast by Application (2017-2022)

11.4 United States Microbiome Therapeutics Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Microbiome Therapeutics

Figure United States Microbiome Therapeutics Market Size () by Type (2012-2022)

Figure United States Microbiome Therapeutics Sales Volume Market Share by Type (Product Category) in 2016

Figure Probiotic Type Product Picture

Figure Fructo-Oligosaccharides Product Picture

Figure Galacto-Oligosaccharides Product Picture

Figure Inulin Product Picture

Figure United States Microbiome Therapeutics Market Size () by Application (2012-2022)

Figure United States Sales Market Share of Microbiome Therapeutics by Application in 2016

Figure Antibiotic-Associated Diarrhoea (AAD) Examples

Figure Infectious Childhood Diarrhoea Examples

Figure Cholesterol Examples

Figure Inflammatory Bowel Disease (IBD) Examples

Figure Blood Pressure Examples

Figure Lactose Intolerance Examples

Figure Weight Loss Examples

Figure Vitamin Production Examples

Figure Bacterial Vaginosis (BV) Examples

Figure Others Examples

Figure United States Microbiome Therapeutics Market Size (Million USD) by Region (2012-2022)

Figure The West Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Middle Atlantic Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)

Figure New England Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)

Figure The South of US Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Midwest Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Microbiome Therapeutics Sales () and Growth Rate (2012-2022)

Figure United States Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Microbiome Therapeutics Market Major Players Product Sales Volume () (2012-2017)

Table United States Microbiome Therapeutics Sales () of Key Players/Suppliers (2012-2017)

Table United States Microbiome Therapeutics Sales Share by Players/Suppliers (2012-2017)

Figure 2016 United States Microbiome Therapeutics Sales Share by Players/Suppliers

Figure 2017 United States Microbiome Therapeutics Sales Share by Players/Suppliers

Figure United States Microbiome Therapeutics Market Major Players Product Revenue (Million USD) (2012-2017)

Table United States Microbiome Therapeutics Revenue (Million USD) by Players/Suppliers (2012-2017)

Table United States Microbiome Therapeutics Revenue Share by Players/Suppliers (2012-2017)

Figure 2016 United States Microbiome Therapeutics Revenue Share by Players/Suppliers

Figure 2017 United States Microbiome Therapeutics Revenue Share by Players/Suppliers

Table United States Market Microbiome Therapeutics Average Price () of Key Players/Suppliers (2012-2017)

Figure United States Market Microbiome Therapeutics Average Price () of Key Players/Suppliers in 2016

Figure United States Microbiome Therapeutics Market Share of Top 3 Players/Suppliers

Figure United States Microbiome Therapeutics Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers Microbiome Therapeutics Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers Microbiome Therapeutics Product Category

Table United States Microbiome Therapeutics Sales () by Region (2012-2017)

Table United States Microbiome Therapeutics Sales Share by Region (2012-2017)

Figure United States Microbiome Therapeutics Sales Share by Region (2012-2017)

Figure United States Microbiome Therapeutics Sales Market Share by Region in 2016

Table United States Microbiome Therapeutics Revenue (Million USD) and Market Share by Region (2012-2017)

Table United States Microbiome Therapeutics Revenue Share by Region (2012-2017)

Figure United States Microbiome Therapeutics Revenue Market Share by Region (2012-2017)

Figure United States Microbiome Therapeutics Revenue Market Share by Region in 2016

Table United States Microbiome Therapeutics Price () by Region (2012-2017)

Table United States Microbiome Therapeutics Sales () by Type (2012-2017)

Table United States Microbiome Therapeutics Sales Share by Type (2012-2017)

Figure United States Microbiome Therapeutics Sales Share by Type (2012-2017)

Figure United States Microbiome Therapeutics Sales Market Share by Type in 2016

Table United States Microbiome Therapeutics Revenue (Million USD) and Market Share by Type (2012-2017)

Table United States Microbiome Therapeutics Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Microbiome Therapeutics by Type (2012-2017)

Figure Revenue Market Share of Microbiome Therapeutics by Type in 2016

Table United States Microbiome Therapeutics Price () by Types (2012-2017)

Figure United States Microbiome Therapeutics Sales Growth Rate by Type (2012-2017)

Table United States Microbiome Therapeutics Sales () by Application (2012-2017)

Table United States Microbiome Therapeutics Sales Market Share by Application (2012-2017)

Figure United States Microbiome Therapeutics Sales Market Share by Application (2012-2017)

Figure United States Microbiome Therapeutics Sales Market Share by Application in 2016

Table United States Microbiome Therapeutics Sales Growth Rate by Application (2012-2017)

Figure United States Microbiome Therapeutics Sales Growth Rate by Application (2012-2017)

Table C3 Jian Basic Information List

Table C3 Jian Microbiome Therapeutics Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)

Figure C3 Jian Microbiome Therapeutics Sales Growth Rate (2012-2017)

Figure C3 Jian Microbiome Therapeutics Sales Market Share in United States (2012-2017)

Figure C3 Jian Microbiome Therapeutics Revenue Market Share in United States (2012-2017)

Table Enterome Bioscience Basic Information List

Table Enterome Bioscience Microbiome Therapeutics Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)

Figure Enterome Bioscience Microbiome Therapeutics Sales Growth Rate (2012-2017)

Figure Enterome Bioscience Microbiome Therapeutics Sales Market Share in United States (2012-2017)

Figure Enterome Bioscience Microbiome Therapeutics Revenue Market Share in United States (2012-2017)

Table Immuron Basic Information List

Table Immuron Microbiome Therapeutics Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)

Figure Immuron Microbiome Therapeutics Sales Growth Rate (2012-2017)

Figure Immuron Microbiome Therapeutics Sales Market Share in United States (2012-2017)

Figure Immuron Microbiome Therapeutics Revenue Market Share in United States (2012-2017)

Table MicroBiome Therapeutics Basic Information List

Table MicroBiome Therapeutics Microbiome Therapeutics Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)

Figure MicroBiome Therapeutics Microbiome Therapeutics Sales Growth Rate (2012-2017)

Figure MicroBiome Therapeutics Microbiome Therapeutics Sales Market Share in United States (2012-2017)

Figure MicroBiome Therapeutics Microbiome Therapeutics Revenue Market Share in United States (2012-2017)

Table OpenBiome Basic Information List

Table OpenBiome Microbiome Therapeutics Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)

Figure OpenBiome Microbiome Therapeutics Sales Growth Rate (2012-2017)

Figure OpenBiome Microbiome Therapeutics Sales Market Share in United States (2012-2017)

Figure OpenBiome Microbiome Therapeutics Revenue Market Share in United States (2012-2017)

Table Osel Basic Information List

Table Osel Microbiome Therapeutics Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)

Figure Osel Microbiome Therapeutics Sales Growth Rate (2012-2017)

Figure Osel Microbiome Therapeutics Sales Market Share in United States (2012-2017)

Figure Osel Microbiome Therapeutics Revenue Market Share in United States (2012-2017)

Table Ritter Pharmaceuticals Basic Information List

Table Ritter Pharmaceuticals Microbiome Therapeutics Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)

Figure Ritter Pharmaceuticals Microbiome Therapeutics Sales Growth Rate (2012-2017)

Figure Ritter Pharmaceuticals Microbiome Therapeutics Sales Market Share in United States (2012-2017)

Figure Ritter Pharmaceuticals Microbiome Therapeutics Revenue Market Share in United States (2012-2017)

Table Second Genome Basic Information List

Table Second Genome Microbiome Therapeutics Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)

Figure Second Genome Microbiome Therapeutics Sales Growth Rate (2012-2017)

Figure Second Genome Microbiome Therapeutics Sales Market Share in United States (2012-2017)

Figure Second Genome Microbiome Therapeutics Revenue Market Share in United States (2012-2017)

Table Seres Therapeutics Basic Information List

Table Seres Therapeutics Microbiome Therapeutics Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)

Figure Seres Therapeutics Microbiome Therapeutics Sales Growth Rate (2012-2017)

Figure Seres Therapeutics Microbiome Therapeutics Sales Market Share in United States (2012-2017)

Figure Seres Therapeutics Microbiome Therapeutics Revenue Market Share in United States (2012-2017)

Table Synthetic Biologics Basic Information List

Table Synthetic Biologics Microbiome Therapeutics Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)

Figure Synthetic Biologics Microbiome Therapeutics Sales Growth Rate (2012-2017)

Figure Synthetic Biologics Microbiome Therapeutics Sales Market Share in United States (2012-2017)

Figure Synthetic Biologics Microbiome Therapeutics Revenue Market Share in United States (2012-2017)

Table 4D Pharma Basic Information List

Table AbbVie Basic Information List

Table ActoGeniX Basic Information List

Table Admera Health Basic Information List

Table Advanced Technology Ventures Basic Information List

Table Advancing Bio Basic Information List

Table AgBiome Basic Information List

Table AOBiome Basic Information List

Table APC Microbiome Institute Basic Information List

Table Assembly Biosciences Basic Information List

Table Avid Biotics Basic Information List

Table Azitra Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Microbiome Therapeutics

Figure Manufacturing Process Analysis of Microbiome Therapeutics

Figure Microbiome Therapeutics Industrial Chain Analysis

Table Raw Materials Sources of Microbiome Therapeutics Major Players/Suppliers in 2016

Table Major Buyers of Microbiome Therapeutics

Table Distributors/Traders List

Figure United States Microbiome Therapeutics Sales Volume () and Growth Rate Forecast (2017-2022)

Figure United States Microbiome Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure United States Microbiome Therapeutics Price () Trend Forecast (2017-2022)

Table United States Microbiome Therapeutics Sales Volume () Forecast by Type (2017-2022)

Figure United States Microbiome Therapeutics Sales Volume () Forecast by Type (2017-2022)

Figure United States Microbiome Therapeutics Sales Volume () Forecast by Type in 2022

Table United States Microbiome Therapeutics Sales Volume () Forecast by Application (2017-2022)

Figure United States Microbiome Therapeutics Sales Volume () Forecast by Application (2017-2022)

Figure United States Microbiome Therapeutics Sales Volume () Forecast by Application in 2022

Table United States Microbiome Therapeutics Sales Volume () Forecast by Region (2017-2022)

Table United States Microbiome Therapeutics Sales Volume Share Forecast by Region (2017-2022)

Figure United States Microbiome Therapeutics Sales Volume Share Forecast by Region (2017-2022)

Figure United States Microbiome Therapeutics Sales Volume Share Forecast by Region in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370